A Drug‐Drug Interaction Study to Evaluate the Impact of Rimegepant on OCT2‐ and MATE1‐Mediated Transport of Metformin in Healthy Participants

Documents similaires

• A Phase 1, Randomized, Placebo‐Controlled, Multiple‐Dose, Double‐Blind Study to Evaluate and Compare the Pharmacokinetics and Safety of Rimegepant in Healthy Adult Japanese and Caucasian Individuals
  par: Rajinder Bhardwaj, et autres
  Publié: (2025)
• Assessment of Pharmacokinetic Drug Interaction of Asciminib with Atorvastatin in Healthy Participants
  par: Matthias Hoch, et autres
  Publié: (2025)
• Phase 1 Studies to Assess Inhaled Seralutinib as a Perpetrator or a Victim of Drug‐Drug Interactions in Healthy Participants
  par: Jianke Li, et autres
  Publié: (2024)
• Pharmacokinetics and Safety of Atogepant Co‐administered with Quinidine Gluconate in Healthy Participants: A Phase 1, Open‐Label, Drug‐Drug Interaction Study
  par: Ramesh Boinpally, et autres
  Publié: (2024)
• Pharmacokinetic Evaluation of the CYP3A4 and CYP2C9 Drug‐Drug Interaction of Avacopan in 2 Open‐Label Studies in Healthy Participants
  par: Shichang Miao, et autres
  Publié: (2024)